Cargando…
A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2
The most common congenital disorder of glycosylation (CDG), phosphomannomutase 2 (PMM2)-CDG, is caused by mutations in PMM2 that limit availability of mannose precursors required for protein N-glycosylation. The disorder has no therapy and there are no models to test new treatments. We generated com...
Autores principales: | Chan, Barden, Clasquin, Michelle, Smolen, Gromoslaw A., Histen, Gavin, Powe, Josh, Chen, Yue, Lin, Zhizhong, Lu, Chenming, Liu, Yan, Cang, Yong, Yan, Zhonghua, Xia, Yuanfeng, Thompson, Ryan, Singleton, Chris, Dorsch, Marion, Silverman, Lee, Su, Shin-San Michael, Freeze, Hudson H., Jin, Shengfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081049/ https://www.ncbi.nlm.nih.gov/pubmed/27053713 http://dx.doi.org/10.1093/hmg/ddw085 |
Ejemplares similares
-
A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency
por: Cline, Abigail, et al.
Publicado: (2012) -
Protease-dependent defects in N-cadherin processing drive PMM2-CDG pathogenesis
por: Klaver, Elsenoor J., et al.
Publicado: (2021) -
Evaluation of Cell Models to Study Monocyte Functions in PMM2 Congenital Disorders of Glycosylation
por: de Haas, Paola, et al.
Publicado: (2022) -
PMM no. 9
Publicado: (1980) -
PMM no. 20
Publicado: (1980)